Personalized medicine in oncology: tailoring the right drug to the right patient

Yuqiu Jiang1, Mu Wang

  • 1Veridex, LLC, a Johnson & Johnson Company, Raritan, NJ, USA.

Biomarkers in Medicine
|August 13, 2010
PubMed

Insights

Personalized medicine uses genomics and proteomics to tailor cancer treatments, aiming to improve patient survival and reduce toxicity. Advances in molecular profiling offer hope for more effective cancer care.

Area of Science:

  • Oncology
  • Genomics
  • Proteomics

Background:

  • Cancer treatment advances have yielded marginal survival improvements.
  • Current cancer diagnosis and prognosis remain suboptimal for many patients.

Purpose of the Study:

  • To highlight the potential of personalized medicine in oncology.
  • To discuss the role of genomics and proteomics in tailoring cancer therapy.
  • To emphasize the need for predictive biomarkers in cancer treatment.

Main Methods:

  • Molecular profiling using genomics and proteomics.
  • Identification of predictive biomarkers for treatment decisions.

Main Results:

  • Genomics and proteomics enable tailored cancer therapy.
  • Personalized medicine approaches show promise for improving efficacy and minimizing toxicity.

Conclusions:

  • Personalized medicine, driven by molecular profiling, offers a promising strategy for improving cancer patient outcomes.
  • Continued technological development is crucial for integrating genomic and proteomic testing into clinical practice.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...